{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:17:19Z","timestamp":1778156239026,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01456-4","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:54:27Z","timestamp":1778154867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ketotifen for Preventing Oxaliplatin-Induced Neuropathy in Stage III Colorectal Cancer: a Randomized Controlled Trial"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6838-2581","authenticated-orcid":false,"given":"Salma S.","family":"Wahby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-5416","authenticated-orcid":false,"given":"Tarek M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1514-9591","authenticated-orcid":false,"given":"Mohamed A. Alm","family":"El-Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-235X","authenticated-orcid":false,"given":"Eman I.","family":"Elberri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"19","key":"1456_CR1","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-16-3224","volume":"23","author":"ME Dolan","year":"2017","unstructured":"Dolan ME, El Charif O, Wheeler HE, Lenz HJ, Hamilton G, Motsinger-Reif A, et al. Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer. Clin Cancer Res. 2017;23(19):5757\u201368. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3224.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ctrv.2014.02.006","volume":"40","author":"DL Nielsen","year":"2014","unstructured":"Nielsen DL, Palshof JA, Larsen FO, Pfeiffer P, Jensen BV. A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +\/\u2212 targeted therapy. Cancer Treat Rev. 2014;40(6):701\u201315. https:\/\/doi.org\/10.1016\/j.ctrv.2014.02.006.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"1456_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003.","journal-title":"Ann Oncol"},{"issue":"12","key":"1456_CR4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1080\/17425255.2016.1223625","volume":"12","author":"CH Han","year":"2016","unstructured":"Han CH, Kilfoyle DH, Hill AG, Shinde SS, Lubel JS, Stylli SS, et al. Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics. Expert Opin Drug Metab Toxicol. 2016;12(12):1479\u201390. https:\/\/doi.org\/10.1080\/17425255.2016.1223625.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"e0186250","DOI":"10.1371\/journal.pone.018625","volume":"12","author":"P Marmiroli","year":"2017","unstructured":"Marmiroli P, Riva B, Pozzi E, Ballarini E, Lim D, Chiorazzi A, et al. Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: phenotypic and genotypic insights. PLoS ONE. 2017;12(10):e0186250. https:\/\/doi.org\/10.1371\/journal.pone.018625.","journal-title":"PLoS ONE"},{"issue":"28","key":"1456_CR6","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"DL Hershman","year":"2020","unstructured":"Hershman DL, Lacchetti C, Loprinzi CL, Rosenberg SA, Cavaletti G, Cavaletto LB, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325\u201348. https:\/\/doi.org\/10.1200\/JCO.20.01399.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1456_CR7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306\u201319. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.003.","journal-title":"Ann Oncol"},{"key":"1456_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1345811","volume":"17","author":"X Chen","year":"2024","unstructured":"Chen X, Gan Y, Au NPB, Ma CHE. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci. 2024;17:1345811. https:\/\/doi.org\/10.3389\/fnmol.2024.1345811.","journal-title":"Front Mol Neurosci"},{"key":"1456_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2019.102128","volume":"86","author":"A Potenzieri","year":"2020","unstructured":"Potenzieri A, Riva B, Genazzani A. Unexpected Ca2+-mobilization of oxaliplatin via H1 histamine receptors. Cell Calcium. 2020;86:102128. https:\/\/doi.org\/10.1016\/j.ceca.2019.102128.","journal-title":"Cell Calcium"},{"issue":"2","key":"1456_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ddr.21865","volume":"83","author":"AKG \u00c5berg","year":"2022","unstructured":"\u00c5berg AKG, Arulnesan N, Bolger GT, Liptrott NJ, Al-Mosawi A, De Luca E, et al. Ketotifen is a prodrug: norketotifen is the active metabolite. Drug Dev Res. 2022;83(2):362\u20137. https:\/\/doi.org\/10.1002\/ddr.21865.","journal-title":"Drug Dev Res"},{"issue":"4","key":"1456_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1507\/endocrj.EJ16-0458","volume":"64","author":"Z Chen","year":"2017","unstructured":"Chen Z, Sun H, Wang J, Yu X, Zhang L, Liu Y, et al. Role of ketotifen on metabolic profiles, inflammation and oxidative stress in diabetic rats. Endocr J. 2017;64(4):411\u20136. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0458.","journal-title":"Endocr J"},{"issue":"3","key":"1456_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2165\/00003495-199040030-00006","volume":"40","author":"SM Grant","year":"1990","unstructured":"Grant SM, Goa KL, Fitton A, Sorkin EM. Ketotifen. Drugs. 1990;40(3):412\u201348. https:\/\/doi.org\/10.2165\/00003495-199040030-00006.","journal-title":"Drugs"},{"issue":"1\u20132","key":"1456_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jneuroim.2004.05.007","volume":"153","author":"CA Massaad","year":"2004","unstructured":"Massaad CA, Safieh-Garabedian B, Poole S, Atweh S, Jabbur S, Saad\u00e9 NE, et al. Involvement of substance P, CGRP and histamine in the hyperalgesia and cytokine upregulation induced by intraplantar injection of capsaicin in rats. J Neuroimmunol. 2004;153(1\u20132):171\u201382. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.05.007.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"e902","DOI":"10.1097\/PR9.0000000000000902","volume":"6","author":"CB Meloto","year":"2021","unstructured":"Meloto CB, Ingelmo P, Perez EV, Ribeiro-Da-Silva A, Franceschini A, de Lima JBM, et al. Mast cell stabilizer ketotifen fumarate reverses inflammatory but not neuropathic-induced mechanical pain in mice. Pain Rep. 2021;6(1):e902. https:\/\/doi.org\/10.1097\/PR9.0000000000000902.","journal-title":"Pain Rep"},{"key":"1456_CR15","unstructured":"-National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 [Internet]. Bethesda (MD): National Cancer Institute. 2009. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"},{"issue":"6","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.4103\/jcrt.JCRT_1123_19","volume":"17","author":"T Aoyama","year":"2021","unstructured":"Aoyama T, Morita S, Kono T, Matsumoto H, Takeda K, Hamaguchi T, et al. Effects of Goshajinkigan (TJ-107) on oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy\/gynecologic oncology group 12-item neurotoxicity questionnaire in a phase II, multicenter, randomized, double-blind, placebo-controlled trial. J Cancer Res Ther. 2021;17(6):1473\u20138. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1123_19.","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"1456_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/cncr.11561","volume":"98","author":"EA Calhoun","year":"2003","unstructured":"Calhoun EA, Welshman EE, Chang CH, Lurain JR, Fishman DA, Hunt TL, et al. Psychometric evaluation of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group\u2013Neurotoxicity (FACT\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Cancer. 2003;98(4):822\u201331. https:\/\/doi.org\/10.1002\/cncr.11561.","journal-title":"Cancer"},{"key":"1456_CR18","unstructured":"-Functional Assessment of Chronic Illness Therapy (FACIT). FACT\/GOG-Ntx-12 Arabic version [Internet]. Chicago (IL): FACIT.org; [cited 2024 Jul 10]. Available from: https:\/\/www.facit.org\/measures\/fact-gog-ntx-12"},{"issue":"8","key":"1456_CR19","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.ajem.2019.158489","volume":"38","author":"M Bahreini","year":"2020","unstructured":"Bahreini M, Safaie A, Mirfazaelian H, Jalili M. How much change in pain score really matter to patients? Am J Emerg Med. 2020;38(8):1641\u20136. https:\/\/doi.org\/10.1016\/j.ajem.2019.158489.","journal-title":"Am J Emerg Med"},{"key":"1456_CR20","unstructured":"-Cleeland CS. The Brief Pain Inventory (BPI) User Guide [Internet]. Houston (TX): MD Anderson Symptom Research; [cited 2024 Jul 10]. Available from: http:\/\/www.mdanderson.org\/education-and-research\/departments-programs-and-labs\/departments-and-divisions\/symptom-research\/symptom-assessment-tools\/BPI_UserGuide.pdf"},{"key":"1456_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2015.03.086","volume":"778","author":"TC Theoharides","year":"2016","unstructured":"Theoharides TC, Stewart JM, Panagiotidou S, Melamed I. Mast cells, brain inflammation and autism. Eur J Pharmacol. 2016;778:96\u2013102. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.086.","journal-title":"Eur J Pharmacol"},{"key":"1456_CR22","doi-asserted-by":"publisher","first-page":"10002992","DOI":"10.3389\/fphar.2023.10002992","volume":"14","author":"D Lauritano","year":"2023","unstructured":"Lauritano D, Della Vella F, Sculco M, Moreo G, Carinci F, Palmieri A, et al. Activation of mast cells by neuropeptides: the role of pro-inflammatory mediators in neuropathic pain. Front Pharmacol. 2023;14:10002992. https:\/\/doi.org\/10.3389\/fphar.2023.10002992.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1456_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13181-012-0239-x","volume":"9","author":"MS Al Moundhri","year":"2013","unstructured":"Al Moundhri MS, Al-Salam S, Al Mahrouqee A, Beegam S, Ali BH. Effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies. J Med Toxicol. 2013;9(1):25\u201333. https:\/\/doi.org\/10.1007\/s13181-012-0239-x.","journal-title":"J Med Toxicol"},{"issue":"2","key":"1456_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.15171\/apb.2015.030","volume":"5","author":"M Anoush","year":"2015","unstructured":"Anoush M, Mohammad Khani MR. Evaluating the anti-nociceptive and anti-inflammatory effects of ketotifen and fexofenadine in rats. Adv Pharm Bull. 2015;5(2):217\u201322. https:\/\/doi.org\/10.15171\/apb.2015.030.","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"1456_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1172\/JCI4217","volume":"103","author":"I Castagliuolo","year":"1999","unstructured":"Castagliuolo I, Wang CC, Valenick L, Pasha A, Nikulasson S, Carraway RE, et al. Neurotensin is a pro-inflammatory neuropeptide in colonic inflammation. J Clin Invest. 1999;103(6):843\u20139. https:\/\/doi.org\/10.1172\/JCI4217.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"1456_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11010-023-04757-5","volume":"479","author":"D Khayatan","year":"2024","unstructured":"Khayatan D, Razavi SM, Arab ZN, Zarezadeh M, Ghorbani A, Khosravi A, et al. Superoxide dismutase: a key target for the neuroprotective effects of curcumin. Mol Cell Biochem. 2024;479(1\u20132):693\u2013705. https:\/\/doi.org\/10.1007\/s11010-023-04757-5.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1456_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ibroneuro.2023.100228","volume":"1","author":"SB Chidambaram","year":"2024","unstructured":"Chidambaram SB. Superoxide dismutase and neurological disorders. iBrain Rep. 2024;1(1):1\u20139. https:\/\/doi.org\/10.1016\/j.ibroneuro.2023.100228.","journal-title":"iBrain Rep"},{"issue":"10","key":"1456_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/00001813-200011000-00005","volume":"11","author":"H Ulrich-Pur","year":"2000","unstructured":"Ulrich-Pur H, Hinterberger W, Raderer M, Z\u00f6chbauer S, Sch\u00fcll B, Haider K, et al. Oxaliplatin-induced fever and release of interleukin-6. Anticancer Drugs. 2000;11(10):779\u201381. https:\/\/doi.org\/10.1097\/00001813-200011000-00005.","journal-title":"Anticancer Drugs"},{"key":"1456_CR29","first-page":"237","volume":"10","author":"N Tyagi","year":"2017","unstructured":"Tyagi N, Goel R. Effect of mast cell stabilizer ketotifen on sciatic nerve ligation-induced experimental neuropathic pain in Wistar rats. World J Pharm Sci. 2017;10:237\u201345.","journal-title":"World J Pharm Sci"},{"issue":"2 Suppl","key":"1456_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.12.767","volume":"129","author":"N Berlin","year":"2012","unstructured":"Berlin N, Maclachlan S, Leader N, Penn D, Sussman G. A prospective, randomized, case-controlled pilot study to evaluate the effect of ketotifen on the adverse events associated with peanut desensitization in children with peanut allergies. J Allergy Clin Immunol. 2012;129(2 Suppl):AB28.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1456_CR31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/AJP.0000000000000169","volume":"31","author":"DC Ang","year":"2015","unstructured":"Ang DC, Hilligoss J, Stump T. Mast cell stabilizer (ketotifen) in fibromyalgia. Clin J Pain. 2015;31(10):836\u201342. https:\/\/doi.org\/10.1097\/AJP.0000000000000169.","journal-title":"Clin J Pain"},{"key":"1456_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/281531","volume":"2010","author":"A Starkweather","year":"2010","unstructured":"Starkweather A, Lyon DE, Berbaum ML, Reilly A, Maixner W, Huh B. Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment. Nurs Res Pract. 2010;2010:281531. https:\/\/doi.org\/10.1155\/2010\/281531.","journal-title":"Nurs Res Pract"},{"issue":"7","key":"1456_CR33","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s00125-014-3220-6","volume":"57","author":"D Ziegler","year":"2014","unstructured":"Ziegler D, Strom A, Nowotny B, Zahiragic L, Nowotny P, Carstensen-Kirberg M, et al. Elevated serum interleukin-6 predicts the development and progression of diabetic polyneuropathy. Diabetologia. 2014;57(7):1448\u201356. https:\/\/doi.org\/10.1007\/s00125-014-3220-6.","journal-title":"Diabetologia"},{"issue":"3","key":"1456_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejr.2018.11.004","volume":"41","author":"AM El-Barbary","year":"2019","unstructured":"El-Barbary AM, Abdel Khalek MA, El-Sergany MA, Mahmoud AA. Serum interleukin-6 and interleukin-10 in diabetic neuropathy: correlation with clinical severity and nerve conduction studies. Egypt Rheumatol. 2019;41(3):203\u20138.","journal-title":"Egypt Rheumatol"},{"key":"1456_CR35","volume":"59","author":"AM Abdelsalam","year":"2023","unstructured":"Abdelsalam AM, Mohy El-Din MM, Osman HG, Shalaby NM. Early detection of peripheral neuropathy in patients with type 2 diabetes mellitus: the role of interleukin-6. Egypt J Neurol Psychiatry Neurosurg. 2023;59:76.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"issue":"1","key":"1456_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","volume":"12","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi N, Kobayashi Y, Kishioka S. Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol. 2012;12(1):55\u201361. https:\/\/doi.org\/10.1016\/j.coph.2011.10.007.","journal-title":"Curr Opin Pharmacol"},{"key":"1456_CR37","doi-asserted-by":"publisher","first-page":"174121","DOI":"10.1016\/j.ejphar.2021.174121","volume":"902","author":"W Wang","year":"2021","unstructured":"Wang W, Guo W, Li H, Zhang C, Xu Y, Wu S, et al. Ketotifen attenuates oxaliplatin-induced peripheral neuropathy by inhibiting spinal glial activation and neuroinflammation in rats. Eur J Pharmacol. 2021;902:174121. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174121.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1456_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/AJP.0000000000000933","volume":"37","author":"SU Jumbo","year":"2021","unstructured":"Jumbo SU, MacDermid JC, Kalu ME, Dickerson CR, Packham TL, Walton DM, et al. Measurement properties of the Brief Pain Inventory-Short Form (BPI-SF) and revised Short McGill Pain Questionnaire Version-2 (SF-MPQ-2) in pain-related musculoskeletal conditions. Clin J Pain. 2021;37(6):454\u201374. https:\/\/doi.org\/10.1097\/AJP.0000000000000933.","journal-title":"Clin J Pain"},{"key":"1456_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173481","volume":"881","author":"M Sisignano","year":"2020","unstructured":"Sisignano M, Baron R, Scholich K, Geisslinger G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Eur J Pharmacol. 2020;881:173481. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173481.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1456_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10549-024-07342-6","volume":"206","author":"K Saint","year":"2024","unstructured":"Saint K, Nemirovsky D, Lessing A, Chen Y, Yang M, Underwood WP, et al. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer. Breast Cancer Res Treat. 2024;206(3):667\u201375. https:\/\/doi.org\/10.1007\/s10549-024-07342-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"31","key":"1456_CR41","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1523\/JNEUROSCI.1064-21.2022","volume":"42","author":"J Shannonhouse","year":"2022","unstructured":"Shannonhouse J, Bernabucci M, Gomez R, Son H, Zhang Y, Ai CH, et al. Meclizine and metabotropic glutamate receptor agonists attenuate severe pain and Ca2\u2009+\u2009activity of primary sensory neurons in chemotherapy-induced peripheral neuropathy. J Neurosci. 2022;42(31):6020\u201337. https:\/\/doi.org\/10.1523\/JNEUROSCI.1064-21.2022.","journal-title":"J Neurosci"},{"issue":"30","key":"1456_CR42","doi-asserted-by":"publisher","first-page":"21082","DOI":"10.1074\/jbc.M114.569574","volume":"289","author":"K Janes","year":"2014","unstructured":"Janes K, Little JW, Li C, Bryant L, Chen C, Chen Z, et al. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. J Biol Chem. 2014;289(30):21082\u201397. https:\/\/doi.org\/10.1074\/jbc.M114.569574.","journal-title":"J Biol Chem"},{"key":"1456_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173481","volume":"888","author":"L Rukh","year":"2020","unstructured":"Rukh L, Ali G, Ullah R, Islam NU, Shahid M. Efficacy assessment of salicylidene salicylhydrazide in chemotherapy associated peripheral neuropathy. Eur J Pharmacol. 2020;888:173481. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173481.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1456_CR44","first-page":"1325","volume":"35","author":"MB Passani","year":"2011","unstructured":"Passani MB, Blandina P. Histamine receptors in the CNS as targets for therapeutic intervention. Neurosci Biobehav Rev. 2011;35(6):1325\u201340.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"1456_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s002280050087","volume":"50","author":"J Ockenga","year":"1996","unstructured":"Ockenga J, Rohde F, S\u00fcttmann U, Herbarth L, Ballmaier M, Schedel I. Ketotifen in HIV-infected patients: effects on body weight and release of TNF-\u03b1. Eur J Clin Pharmacol. 1996;50(2):167\u201370. https:\/\/doi.org\/10.1007\/s002280050087.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01456-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:54:33Z","timestamp":1778154873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01456-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01456-4","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the National Research Ethics Committee of Tanta University (Approval Code: 36030\/11\/22). The study was conducted in accordance with the Declaration of Helsinki 1964.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consents were obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}